The neurodegenerative disease will grow globally by 112% in 2050 compared to 2021, according to the latest estimates ...

A recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking treatment approach for ...

Early use of continuous positive airway pressure (CPAP) therapy for sleep apnea could help lower Parkinson's risk, a large ...

Read More: A Potential Parkinson’s Treatment Has Promising Results That's because deep brain stimulation and Parkinson’s ...

A breakthrough study has uncovered a hidden player in Parkinson’s disease—24-OHC, a cholesterol metabolite that fuels the ...

Parkinson’s disease is set to rise dramatically, with cases expected to more than double by 2050, largely due to an aging ...

A form of Parkinson's disease caused by mutations in a gene known as PINK1 has long been labeled rare. But our research shows ...

The FDA has approved an adaptive deep brain stimulation (aDBS) treatment for people with with Parkinson’s disease, making this groundbreaking technology available to people nationwide.

More advanced methods may enable better modelling Parkinson’s disease is a considerable health problem owing to its high and rising global prevalence, its progressively degenerative nature, and its ...

After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive ...

This recent study highlights the neuroprotective potential of TFE3, a transcription factor that plays a pivotal role in ...

According to a recent study, obstructive sleep apnea is associated with an increased risk for Parkinson disease.